http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Accuray and DHL Supply Chain establish global service logistics platform to support delivery of advanced cancer treatment technology
-
Accuray Appoints Renowned Medical Device Industry Executive Jim Dennison as Senior Vice President of Global Quality and Regulatory Affairs
-
Accuray Showcases Radiation Therapy Innovations Designed to Enable Better Outcomes with Less Damage, Less Time, and Less Cost, at ASTRO 2020
-
Accuray Announces Agreement with Brainlab to Expand CyberKnife® Platform Treatment Capabilities for the Neuro-Radiosurgery Market
-
Accuray Appoints Mike Leischer Vice President and General Manager, Americas Region
-
Accuray To Report First Quarter Fiscal 2021 Financial Results on October 29, 2020
-
Accuray Radixact® System with Synchrony® Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
-
University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology
-
Accuray (ARAY) Names Anne B. Le Grand to Board
-
Anne B. Le Grand Joins Accuray Board of Directors
-
Accuray To Report Fiscal Year-end 2020 Financial Results on August 13, 2020
-
Accuray Launches New CyberKnife® S7™ System
-
Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System Wins 2020 MedTech Breakthrough Award
-
Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020
-
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
-
First Accuray CyberKnife® M6™ System Installed in Missouri at Mercy Hospital St. Louis
-
Accuray (ARAY) Announces Studies Support Use of Accuray TomoTherapy System for Advanced Rectal Cancer to Improve Treatment Efficacy, Reduce Side Effects
-
Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
-
Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020
-
Accuray (ARAY) to Discuss Revenue Growth Expectations for Next Three Fiscal Years at the JP Morgan Healthcare Conference
-
Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
-
Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
-
Accuray to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 15, 2020
-
Timpanogos Cancer Services First in Utah to Offer Precise and Accurate Radiation Treatments with the Accuray Radixact® System
-
Accuray (ARAY) announces Stanford University Medical Center has selected second CyberKnife M6 System
-
Stanford University Medical Center to Acquire Second Accuray CyberKnife® M6™ System
-
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
-
First Asia-Pacific Hospital Treats Patients With RayStation and Radixact
-
First Asia-Pacific hospital treats patients with RayStation and Radixact
-
Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
-
Accuray To Report Fiscal 2020 First Quarter Financial Results on October 29, 2019
-
Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model (RO-APM)
-
Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity (Grade 2 or Higher) Than Patients Treated on a Conventional Linear
-
Accuray (ARAY) Says China Announced Tariff Exclusion for Medical Linear Accelerators
-
China Announces Tariff Exclusion for Medical Linear Accelerators
-
Accuray (ARAY) Adds James M. Hindman to Board
-
Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors
-
Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System
-
Accuray to Set ASTRO 2019 in Motion with Patient-first Cancer Treatment Innovations
-
Accuray to Host ASTRO Investor Meeting on September 16, 2019
-
Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Techno
-
New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine
-
Accuray (ARAY) Provides Update on China Joint Venture Operational Progress
-
Accuray Provides Update on China Joint Venture Operational Progress
-
Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019
-
Swiss Medical Network Advances Cancer Care in Switzerland with Multi-System Agreement for Accuray Radiation Therapy Systems and RaySearch Oncology Software Systems
-
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
-
Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System
-
Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019
-
Accuray (ARAY) Says Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer

